Table 2.

The incidence of VTE events.

Endpoints	Overall (n=1836)	First stage (5−9 days) (n=1743)	Second stage (21−28 days) (n=1204)
VTE, n (%; 95% CI)	205 (11.2; 9.8–12.7)	183 (10.5; 9.1–12.0)	22 (1.8; 1.5–2.8)
PE	3 (0.2; 0−0.5)	3 (0.2; 0−0.5)	0
DVT without PE	202 (11.0; 9.6–12.5)	180 (10.3; 8.9–11.9)	22 (1.8; 1.5–2.8)
Symptom of VTE, n (%; 95% CI)
Symptomatic events	45 (2.5; 1.8–3.3)	41 (2.4; 1.7–3.2)	4 (0.3; 0–0.8)
Asymptomatic events	160 (8.7; 7.5–10.1)	142 (8.1; 6.9–9.5)	18 (1.5; 0.8–2.3)

Data are shown as number (%; 95% CI).

DVT, deep vein thrombosis; PE, pulmonary embolism; VTE, venous thromboembolism.